Oncogenic Tyrosine Kinases Target Dok-1 for Ubiquitin-Mediated Proteasomal Degradation To Promote Cell Transformation
Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue MCB About MCB Subscribers Authors Reviewers Advertisers Inquiries from...
Saved in:
Published in | Molecular and Cellular Biology Vol. 31; no. 13; pp. 2552 - 2565 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
01.07.2011
Taylor & Francis |
Subjects | |
Online Access | Get full text |
ISSN | 0270-7306 1098-5549 1098-5549 |
DOI | 10.1128/MCB.05045-11 |
Cover
Abstract | Article Usage Stats
Services
MCB
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
Spotlights in the Current Issue
MCB
About
MCB
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
MCB
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0270-7306
Online ISSN:
1098-5549
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
MCB
.asm.org, visit:
MCB
|
---|---|
AbstractList | Cellular transformation induced by oncogenic tyrosine kinases is a multistep process involving activation of growth-promoting signaling pathways and inactivation of suppressor molecules. Dok-1 is an adaptor protein that acts as a negative regulator of tyrosine kinase-initiated signaling and opposes oncogenic tyrosine kinase-mediated cell transformation. Findings that its loss facilitates transformation induced by oncogenic tyrosine kinases suggest that Dok-1 inactivation could constitute an intermediate step in oncogenesis driven by these oncoproteins. However, whether Dok-1 is subject to regulation by oncogenic tyrosine kinases remained unknown. In this study, we show that oncogenic tyrosine kinases, including p210(bcr-abl) and oncogenic forms of Src, downregulate Dok-1 by targeting it for degradation through the ubiquitin-proteasome pathway. This process is dependent on the tyrosine kinase activity of the oncoproteins and is mediated primarily by lysine-dependent polyubiquitination of Dok-1. Importantly, restoration of Dok-1 levels strongly suppresses transformation of cells expressing oncogenic tyrosine kinases, and this suppression is more pronounced in the context of a Dok-1 mutant that is largely refractory to oncogenic tyrosine kinase-induced degradation. Our findings suggest that proteasome-mediated downregulation of Dok-1 is a key mechanism by which oncogenic tyrosine kinases overcome the inhibitory effect of Dok-1 on cellular transformation and tumor progression.Cellular transformation induced by oncogenic tyrosine kinases is a multistep process involving activation of growth-promoting signaling pathways and inactivation of suppressor molecules. Dok-1 is an adaptor protein that acts as a negative regulator of tyrosine kinase-initiated signaling and opposes oncogenic tyrosine kinase-mediated cell transformation. Findings that its loss facilitates transformation induced by oncogenic tyrosine kinases suggest that Dok-1 inactivation could constitute an intermediate step in oncogenesis driven by these oncoproteins. However, whether Dok-1 is subject to regulation by oncogenic tyrosine kinases remained unknown. In this study, we show that oncogenic tyrosine kinases, including p210(bcr-abl) and oncogenic forms of Src, downregulate Dok-1 by targeting it for degradation through the ubiquitin-proteasome pathway. This process is dependent on the tyrosine kinase activity of the oncoproteins and is mediated primarily by lysine-dependent polyubiquitination of Dok-1. Importantly, restoration of Dok-1 levels strongly suppresses transformation of cells expressing oncogenic tyrosine kinases, and this suppression is more pronounced in the context of a Dok-1 mutant that is largely refractory to oncogenic tyrosine kinase-induced degradation. Our findings suggest that proteasome-mediated downregulation of Dok-1 is a key mechanism by which oncogenic tyrosine kinases overcome the inhibitory effect of Dok-1 on cellular transformation and tumor progression. Cellular transformation induced by oncogenic tyrosine kinases is a multistep process involving activation of growth-promoting signaling pathways and inactivation of suppressor molecules. Dok-1 is an adaptor protein that acts as a negative regulator of tyrosine kinase-initiated signaling and opposes oncogenic tyrosine kinase-mediated cell transformation. Findings that its loss facilitates transformation induced by oncogenic tyrosine kinases suggest that Dok-1 inactivation could constitute an intermediate step in oncogenesis driven by these oncoproteins. However, whether Dok-1 is subject to regulation by oncogenic tyrosine kinases remained unknown. In this study, we show that oncogenic tyrosine kinases, including p210 bcr-abl and oncogenic forms of Src, downregulate Dok-1 by targeting it for degradation through the ubiquitin-proteasome pathway. This process is dependent on the tyrosine kinase activity of the oncoproteins and is mediated primarily by lysine-dependent polyubiquitination of Dok-1. Importantly, restoration of Dok-1 levels strongly suppresses transformation of cells expressing oncogenic tyrosine kinases, and this suppression is more pronounced in the context of a Dok-1 mutant that is largely refractory to oncogenic tyrosine kinase-induced degradation. Our findings suggest that proteasome-mediated downregulation of Dok-1 is a key mechanism by which oncogenic tyrosine kinases overcome the inhibitory effect of Dok-1 on cellular transformation and tumor progression. Cellular transformation induced by oncogenic tyrosine kinases is a multistep process involving activation of growth-promoting signaling pathways and inactivation of suppressor molecules. Dok-1 is an adaptor protein that acts as a negative regulator of tyrosine kinase-initiated signaling and opposes oncogenic tyrosine kinase-mediated cell transformation. Findings that its loss facilitates transformation induced by oncogenic tyrosine kinases suggest that Dok-1 inactivation could constitute an intermediate step in oncogenesis driven by these oncoproteins. However, whether Dok-1 is subject to regulation by oncogenic tyrosine kinases remained unknown. In this study, we show that oncogenic tyrosine kinases, including p210bcr-abl and oncogenic forms of Src, downregulate Dok-1 by targeting it for degradation through the ubiquitin-proteasome pathway. This process is dependent on the tyrosine kinase activity of the oncoproteins and is mediated primarily by lysine-dependent polyubiquitination of Dok-1. Importantly, restoration of Dok-1 levels strongly suppresses transformation of cells expressing oncogenic tyrosine kinases, and this suppression is more pronounced in the context of a Dok-1 mutant that is largely refractory to oncogenic tyrosine kinase-induced degradation. Our findings suggest that proteasome-mediated downregulation of Dok-1 is a key mechanism by which oncogenic tyrosine kinases overcome the inhibitory effect of Dok-1 on cellular transformation and tumor progression. Cellular transformation induced by oncogenic tyrosine kinases is a multistep process involving activation of growth-promoting signaling pathways and inactivation of suppressor molecules. Dok-1 is an adaptor protein that acts as a negative regulator of tyrosine kinase-initiated signaling and opposes oncogenic tyrosine kinase-mediated cell transformation. Findings that its loss facilitates transformation induced by oncogenic tyrosine kinases suggest that Dok-1 inactivation could constitute an intermediate step in oncogenesis driven by these oncoproteins. However, whether Dok-1 is subject to regulation by oncogenic tyrosine kinases remained unknown. In this study, we show that oncogenic tyrosine kinases, including p210(bcr-abl) and oncogenic forms of Src, downregulate Dok-1 by targeting it for degradation through the ubiquitin-proteasome pathway. This process is dependent on the tyrosine kinase activity of the oncoproteins and is mediated primarily by lysine-dependent polyubiquitination of Dok-1. Importantly, restoration of Dok-1 levels strongly suppresses transformation of cells expressing oncogenic tyrosine kinases, and this suppression is more pronounced in the context of a Dok-1 mutant that is largely refractory to oncogenic tyrosine kinase-induced degradation. Our findings suggest that proteasome-mediated downregulation of Dok-1 is a key mechanism by which oncogenic tyrosine kinases overcome the inhibitory effect of Dok-1 on cellular transformation and tumor progression. Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue MCB About MCB Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy MCB RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0270-7306 Online ISSN: 1098-5549 Copyright © 2014 by the American Society for Microbiology. For an alternate route to MCB .asm.org, visit: MCB |
Author | Justyna A. Janas Linda Van Aelst |
Author_xml | – sequence: 1 givenname: Justyna A. surname: Janas fullname: Janas, Justyna A. organization: Cold Spring Harbor Laboratory, Cold Spring Harbor – sequence: 2 givenname: Linda surname: Van Aelst fullname: Van Aelst, Linda email: vanaelst@cshl.edu organization: Cold Spring Harbor Laboratory, Cold Spring Harbor |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21536658$$D View this record in MEDLINE/PubMed |
BookMark | eNp1Uc9PFDEUbgxGFvTm2TRevDDw2m7nx8VEFwUDBA_juWk7ndnqTAttR7L_PWUXjBo99TXfj5f3fQdoz3lnEHpN4JgQWp9crT4eA4clLwh5hhYEmrrgfNnsoQXQCoqKQbmPDmL8DgBlA-wF2qeEs7Lk9QLN1077wTircbsJPlpn8IV1MpqIWxkGk_Cp_1EQ3PuAvyl7O9tkXXFlOiuT6fDX4JOR0U9yxKdmCLKTyXqHW_8ATRnEKzOOuA3SxewxbeGX6Hkvx2hePb6HqP38qV2dF5fXZ19WHy4LvaSQirpqJORRc6g05Uz2ilDoQVPgFVON6jQtFeRDCC2pKhtOFCjW8EY3lWbsEL3f2d7MajKdNi4FOYqbYCcZNsJLK_5EnF2Lwf8UjDDGapIN3j0aBH87m5jEZKPO90hn_BxFXRFWV0vGM_PN76t-7XhKOhPojqBzyjGYXmibtmHkzXYUBMRDnSLXKbZ15m8WHf0levL9D73a0a3bRn3nw9iJJDejD30uQNuYT_u38u1OubbD-s4GI2ScxKRV5gvCBOWcsnseM78q |
CitedBy_id | crossref_primary_10_18632_oncotarget_2199 crossref_primary_10_1016_j_jare_2021_06_008 crossref_primary_10_1186_s12885_016_2346_6 crossref_primary_10_1016_j_virol_2017_08_018 crossref_primary_10_1371_journal_pone_0107674 crossref_primary_10_1080_2162402X_2019_1649961 crossref_primary_10_1016_j_ebiom_2016_05_003 crossref_primary_10_1371_journal_pone_0087684 crossref_primary_10_1371_journal_pone_0039967 crossref_primary_10_1371_journal_ppat_1004125 crossref_primary_10_4049_jimmunol_1600385 crossref_primary_10_1016_j_bbcan_2015_05_001 crossref_primary_10_1038_cr_2012_47 crossref_primary_10_1038_s42003_024_06771_9 crossref_primary_10_1038_s41375_019_0535_4 |
Cites_doi | 10.1126/science.2408149 10.1128/MCB.20.8.2743-2754.2000 10.1126/science.289.5486.1938 10.1016/S0022-2836(02)01269-X 10.1038/sj.onc.1202171 10.1038/sj.emboj.7600292 10.1038/sj.emboj.7601557 10.1038/onc.2008.242 10.1016/S0092-8674(00)81841-3 10.1111/j.1600-065X.2009.00844.x 10.1073/pnas.97.16.9064 10.1016/j.ccr.2009.05.009 10.1016/0959-437X(94)90086-8 10.1016/S0092-8674(94)90502-9 10.1002/bies.20210 10.1016/S0145-2126(99)00179-4 10.1016/j.biocel.2007.07.012 10.1083/jcb.200312171 10.1074/jbc.M005504200 10.1006/excr.1999.4732 10.1016/j.jmb.2004.08.072 10.1126/science.1127142 10.1128/MCB.19.12.8314 10.1083/jcb.200102032 10.1016/S1074-7613(00)80584-1 10.1016/j.molcel.2007.11.019 10.1038/sj.onc.1203912 10.1101/gad.12.10.1415 10.1093/intimm/dxm015 10.1038/nrm2707 10.1093/emboj/19.19.5114 10.1016/S1074-5521(02)00086-8 10.1074/jbc.M403726200 10.1074/jbc.273.48.32360 10.1073/pnas.0304242101 10.1038/ng.527 10.1016/S0092-8674(00)81840-1 10.1016/S0076-6879(06)06046-0 10.1016/S0968-0004(98)01227-4 10.1016/j.febslet.2009.05.042 10.1016/S0960-9822(99)80458-8 10.1038/343377a0 10.1038/nrc2368 10.1016/S0021-9258(19)78151-4 10.1038/nrc2900 10.1073/pnas.0603948103 10.1126/science.1062538 10.1038/nn1210 10.1038/sj.onc.1202115 10.1074/jbc.273.9.4827 10.1128/MCB.25.9.3831-3841.2005 10.1016/j.ccr.2005.10.015 10.1083/jcb.200707063 10.1038/35077225 10.1074/jbc.M102116200 10.1038/sj.onc.1208796 10.1126/science.1110340 10.1016/j.tcb.2010.01.009 10.1084/jem.194.3.275 10.1084/jem.20041247 10.1016/j.yexcr.2008.07.022 10.1006/meth.2001.1262 10.1084/jem.194.3.265 10.1371/journal.pone.0007728 10.1111/j.1356-9597.2004.00748.x 10.1042/BC20080020 10.1016/j.cellsig.2009.06.002 10.1016/S0092-8674(85)80053-2 10.1128/MCB.26.7.2479-2489.2006 10.1016/j.tcb.2004.01.004 10.1056/NEJMra044389 10.1084/jem.20041306 10.1111/j.1365-2443.2006.00926.x 10.1038/nrc2147 10.1182/blood.V86.6.2371.bloodjournal8662371 10.1093/emboj/18.7.1748 10.1038/sj.onc.1206620 10.1146/annurev.cellbio.22.010605.093503 10.1182/blood.V91.10.3927.3927_3927_3934 10.1016/j.cub.2008.12.007 10.1038/onc.2009.319 10.1126/science.1075762 10.1182/blood-2009-06-228130 10.4049/jimmunol.0901531 10.1093/annonc/mdn048 10.4049/jimmunol.0804172 10.1038/sj.onc.1205317 10.1038/onc.2010.331 10.1016/j.ceb.2009.01.028 10.1006/bbrc.2001.4430 10.1083/jcb.200611063 10.1128/MCB.15.9.4908 |
ContentType | Journal Article |
Copyright | Copyright © 2011, American Society for Microbiology 2011 Copyright © 2011, American Society for Microbiology 2011 American Society for Microbiology |
Copyright_xml | – notice: Copyright © 2011, American Society for Microbiology 2011 – notice: Copyright © 2011, American Society for Microbiology 2011 American Society for Microbiology |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1128/MCB.05045-11 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Biology |
EISSN | 1098-5549 |
EndPage | 2565 |
ExternalDocumentID | PMC3133381 21536658 10_1128_MCB_05045_11 12273105 mcb_31_13_2552 |
Genre | Research Article Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: CA-135053 – fundername: NCI NIH HHS grantid: R01 CA135053 |
GroupedDBID | --- -DZ -~X 0R~ 123 18M 29M 2WC 39C 4.4 53G 5RE 5VS ABTAH ACGFO ACNCT ADBBV ADIYS AENEX AEOZL AGHSJ AGVNZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CS3 DIK DU5 E3Z EBS EJD F5P GX1 H13 HH5 HYE HZ~ IH2 KQ8 L7B M4Z N9A O9- OK1 P2P RHF RHI RNS RPM RSF TDBHL TFL TFW TR2 UCJ UDS VQA W8F WH7 WOQ ZCA ZY4 AAGFI AAYXX ABJNI CITATION TASJS .55 .GJ 3O- 9M8 ABRLO ACKIV ADXHL AFFNX C1A CGR CUY CVF ECM EIF EMOBN MVM NPM WHG X7M Y6R YYP ZGI ZXP 7X8 5PM |
ID | FETCH-LOGICAL-c420t-879a0c42c507c253afb120f0c20573b9bdc26b06581262b6951b0b3959c97c33 |
ISSN | 0270-7306 1098-5549 |
IngestDate | Tue Sep 30 15:46:34 EDT 2025 Fri Sep 05 03:49:57 EDT 2025 Mon Jul 21 06:06:39 EDT 2025 Wed Oct 01 02:24:54 EDT 2025 Thu Apr 24 23:08:12 EDT 2025 Wed Dec 25 09:04:52 EST 2024 Wed May 18 15:25:46 EDT 2016 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 13 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c420t-879a0c42c507c253afb120f0c20573b9bdc26b06581262b6951b0b3959c97c33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 21536658 |
PQID | 871387435 |
PQPubID | 23479 |
PageCount | 14 |
ParticipantIDs | informaworld_taylorfrancis_310_1128_MCB_05045_11 crossref_citationtrail_10_1128_MCB_05045_11 highwire_asm_mcb_31_13_2552 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3133381 proquest_miscellaneous_871387435 crossref_primary_10_1128_MCB_05045_11 pubmed_primary_21536658 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20110701 7/1/2011 2011-07-01 2011-Jul |
PublicationDateYYYYMMDD | 2011-07-01 |
PublicationDate_xml | – month: 07 year: 2011 text: 20110701 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | Molecular and Cellular Biology |
PublicationTitleAlternate | Mol Cell Biol |
PublicationYear | 2011 |
Publisher | American Society for Microbiology Taylor & Francis |
Publisher_xml | – name: American Society for Microbiology – name: Taylor & Francis |
References | Oki S. (B67) 2005; 4 Niki M. (B63) 2004; 200 Janas J. (B38) 2006; 406 Bradshaw R. A. (B10) 1998; 23 Berman E. (B5) 2000; 24 Moran M. F. (B59) 1991; 11 Govek E. E. (B29) 2004; 7 Nelms K. (B61) 1998; 9 Sirvent A. (B79) 2008; 100 Guittard G. (B31) 2009; 182 Titz B. (B84) 2010; 29 McGillicuddy L. T. (B56) 2009; 16 Sabe H. (B73) 1992; 12 Tait S. W. (B83) 2007; 179 Geoffroy M. C. (B26) 2009; 10 Livak K. J. (B50) 2001; 25 Zhao M. (B98) 2006; 26 Lugo T. G. (B51) 1990; 247 Klucher K. M. (B43) 1998; 91 Grimm J. (B30) 2001; 154 Bache K. G. (B2) 2004; 23 Caron C. (B12) 2005; 27 Di Cristofano A. (B21) 2001; 194 Palacios R. (B68) 1985; 41 Wang X. (B89) 2008; 27 Jones N. (B39) 1999; 9 Irby R. B. (B37) 2000; 19 Lee Y. (B48) 2001; 281 Fry W. H. (B24) 2009; 315 Kobayashi R. (B44) 2009; 583 Di Cristofano A. (B20) 1998; 273 Stork B. (B81) 2007; 26 Abram C. L. (B1) 2000; 254 Kirisits A. (B42) 2007; 39 Yasuda T. (B95) 2004; 200 Cadwell K. (B11) 2005; 309 Hosomi Y. (B34) 1994; 269 Ellis C. (B23) 1990; 343 Demers A. (B19) 2009; 4 Bhat A. (B6) 1998; 273 Boettner B. (B8) 2000; 97 Crowder R. J. (B16) 2004; 279 Van Slyke P. (B86) 2005; 25 Treier M. (B85) 1994; 78 Melo J. V. (B57) 2007; 7 Kerscher O. (B41) 2006; 22 Bose R. (B9) 2006; 103 Neviani P. (B62) 2005; 8 Carpino N. (B13) 1997; 88 Wade M. (B87) 2010; 20 Laszlo G. S. (B47) 2009; 19 Yasuda T. (B94) 2007; 19 Cong F. (B15) 1999; 19 Nowicki M. O. (B65) 2003; 22 Barnes D. J. (B3) 2005; 24 Peng C. (B69) 2010; 115 Gaiger A. (B25) 1995; 86 Gorre M. E. (B28) 2001; 293 Zhao M. (B99) 2001; 194 DeClue J. E. (B18) 1993; 13 Krause D. S. (B46) 2005; 353 Manning G. (B52) 2002; 298 Zhang Y. (B97) 2004; 343 Dube N. (B22) 2004; 101 Hunter T (B36) 2009; 21 Schindler T. (B76) 2000; 289 Okada K. (B66) 2006; 312 Polevoda B. (B70) 2003; 325 Suzu S. (B82) 2000; 19 Mashima R. (B54) 2010; 90 Woodring P. J. (B92) 2004; 165 Yamanashi Y. (B93) 1997; 88 Songyang Z. (B80) 2001; 276 Blume-Jensen P. (B7) 2001; 411 Dai Z. (B17) 1998; 12 Kolch W. (B45) 2010; 10 Jones N. (B40) 1998; 17 Wang X. (B88) 2007; 177 Masson K. (B55) 2009; 21 Noguchi T. (B64) 1999; 18 Savona M. (B74) 2008; 8 Porter A. C. (B71) 1998; 17 Shah K. (B77) 2002; 9 Hendrie P. C. (B32) 1991; 19 Mashima R. (B53) 2009; 232 Berger A. H. (B4) 2010; 42 Rodrigues G. A. (B72) 1994; 4 Hunter T (B35) 2007; 28 Yoo Y. (B96) 2010; 29 Scheijen B. (B75) 2002; 21 Lemay S. (B49) 2000; 20 Neet K. (B60) 1995; 15 Ciechanover A. (B14) 2004; 14 Mihrshahi R. (B58) 2009; 183 Shinohara H. (B78) 2004; 9 Wick M. J. (B90) 2001; 276 Honma M. (B33) 2006; 11 Giaccone G. (B27) 2008; 19 Wisniewski D. (B91) 1994; 8 |
References_xml | – volume: 247 start-page: 1079 year: 1990 ident: B51 publication-title: Science doi: 10.1126/science.2408149 – volume: 20 start-page: 2743 year: 2000 ident: B49 publication-title: Mol. Cell. Biol doi: 10.1128/MCB.20.8.2743-2754.2000 – volume: 4 start-page: 310 year: 2005 ident: B67 publication-title: Cell Cycle – volume: 289 start-page: 1938 year: 2000 ident: B76 publication-title: Science doi: 10.1126/science.289.5486.1938 – volume: 325 start-page: 595 year: 2003 ident: B70 publication-title: J. Mol. Biol doi: 10.1016/S0022-2836(02)01269-X – volume: 17 start-page: 1343 year: 1998 ident: B71 publication-title: Oncogene doi: 10.1038/sj.onc.1202171 – volume: 23 start-page: 2707 year: 2004 ident: B2 publication-title: EMBO J doi: 10.1038/sj.emboj.7600292 – volume: 26 start-page: 1140 year: 2007 ident: B81 publication-title: EMBO J doi: 10.1038/sj.emboj.7601557 – volume: 27 start-page: 5454 year: 2008 ident: B89 publication-title: Oncogene doi: 10.1038/onc.2008.242 – volume: 88 start-page: 205 year: 1997 ident: B93 publication-title: Cell doi: 10.1016/S0092-8674(00)81841-3 – volume: 232 start-page: 273 year: 2009 ident: B53 publication-title: Immunol. Rev doi: 10.1111/j.1600-065X.2009.00844.x – volume: 97 start-page: 9064 year: 2000 ident: B8 publication-title: Proc. Natl. Acad. Sci. U. S. A doi: 10.1073/pnas.97.16.9064 – volume: 16 start-page: 44 year: 2009 ident: B56 publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.05.009 – volume: 4 start-page: 15 year: 1994 ident: B72 publication-title: Curr. Opin. Genet. Dev doi: 10.1016/0959-437X(94)90086-8 – volume: 78 start-page: 787 year: 1994 ident: B85 publication-title: Cell doi: 10.1016/S0092-8674(94)90502-9 – volume: 27 start-page: 408 year: 2005 ident: B12 publication-title: Bioessays doi: 10.1002/bies.20210 – volume: 11 start-page: 1804 year: 1991 ident: B59 publication-title: Mol. Cell. Biol – volume: 24 start-page: 289 year: 2000 ident: B5 publication-title: Leuk. Res doi: 10.1016/S0145-2126(99)00179-4 – volume: 39 start-page: 2173 year: 2007 ident: B42 publication-title: Int. J. Biochem. Cell Biol doi: 10.1016/j.biocel.2007.07.012 – volume: 165 start-page: 493 year: 2004 ident: B92 publication-title: J. Cell Biol doi: 10.1083/jcb.200312171 – volume: 276 start-page: 2459 year: 2001 ident: B80 publication-title: J. Biol. Chem doi: 10.1074/jbc.M005504200 – volume: 254 start-page: 1 year: 2000 ident: B1 publication-title: Exp. Cell Res doi: 10.1006/excr.1999.4732 – volume: 343 start-page: 1147 year: 2004 ident: B97 publication-title: J. Mol. Biol doi: 10.1016/j.jmb.2004.08.072 – volume: 312 start-page: 1802 year: 2006 ident: B66 publication-title: Science doi: 10.1126/science.1127142 – volume: 19 start-page: 8314 year: 1999 ident: B15 publication-title: Mol. Cell. Biol doi: 10.1128/MCB.19.12.8314 – volume: 154 start-page: 345 year: 2001 ident: B30 publication-title: J. Cell Biol doi: 10.1083/jcb.200102032 – volume: 9 start-page: 13 year: 1998 ident: B61 publication-title: Immunity doi: 10.1016/S1074-7613(00)80584-1 – volume: 28 start-page: 730 year: 2007 ident: B35 publication-title: Mol. Cell doi: 10.1016/j.molcel.2007.11.019 – volume: 12 start-page: 4706 year: 1992 ident: B73 publication-title: Mol. Cell. Biol – volume: 19 start-page: 5636 year: 2000 ident: B37 publication-title: Oncogene doi: 10.1038/sj.onc.1203912 – volume: 12 start-page: 1415 year: 1998 ident: B17 publication-title: Genes Dev doi: 10.1101/gad.12.10.1415 – volume: 19 start-page: 487 year: 2007 ident: B94 publication-title: Int. Immunol doi: 10.1093/intimm/dxm015 – volume: 10 start-page: 564 year: 2009 ident: B26 publication-title: Nat. Rev. Mol. Cell Biol doi: 10.1038/nrm2707 – volume: 19 start-page: 5114 year: 2000 ident: B82 publication-title: EMBO J doi: 10.1093/emboj/19.19.5114 – volume: 9 start-page: 35 year: 2002 ident: B77 publication-title: Chem. Biol doi: 10.1016/S1074-5521(02)00086-8 – volume: 279 start-page: 42072 year: 2004 ident: B16 publication-title: J. Biol. Chem doi: 10.1074/jbc.M403726200 – volume: 273 start-page: 32360 year: 1998 ident: B6 publication-title: J. Biol. Chem doi: 10.1074/jbc.273.48.32360 – volume: 101 start-page: 1834 year: 2004 ident: B22 publication-title: Proc. Natl. Acad. Sci. U. S. A doi: 10.1073/pnas.0304242101 – volume: 42 start-page: 216 year: 2010 ident: B4 publication-title: Nat. Genet doi: 10.1038/ng.527 – volume: 88 start-page: 197 year: 1997 ident: B13 publication-title: Cell doi: 10.1016/S0092-8674(00)81840-1 – volume: 406 start-page: 593 year: 2006 ident: B38 publication-title: Methods Enzymol doi: 10.1016/S0076-6879(06)06046-0 – volume: 23 start-page: 263 year: 1998 ident: B10 publication-title: Trends Biochem. Sci doi: 10.1016/S0968-0004(98)01227-4 – volume: 583 start-page: 2441 year: 2009 ident: B44 publication-title: FEBS Lett doi: 10.1016/j.febslet.2009.05.042 – volume: 9 start-page: 1057 year: 1999 ident: B39 publication-title: Curr. Biol doi: 10.1016/S0960-9822(99)80458-8 – volume: 343 start-page: 377 year: 1990 ident: B23 publication-title: Nature doi: 10.1038/343377a0 – volume: 8 start-page: 341 year: 2008 ident: B74 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2368 – volume: 269 start-page: 11498 year: 1994 ident: B34 publication-title: J. Biol. Chem doi: 10.1016/S0021-9258(19)78151-4 – volume: 10 start-page: 618 year: 2010 ident: B45 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2900 – volume: 103 start-page: 9773 year: 2006 ident: B9 publication-title: Proc. Natl. Acad. Sci. U. S. A doi: 10.1073/pnas.0603948103 – volume: 293 start-page: 876 year: 2001 ident: B28 publication-title: Science doi: 10.1126/science.1062538 – volume: 7 start-page: 364 year: 2004 ident: B29 publication-title: Nat. Neurosci doi: 10.1038/nn1210 – volume: 17 start-page: 1097 year: 1998 ident: B40 publication-title: Oncogene doi: 10.1038/sj.onc.1202115 – volume: 273 start-page: 4827 year: 1998 ident: B20 publication-title: J. Biol. Chem doi: 10.1074/jbc.273.9.4827 – volume: 13 start-page: 6799 year: 1993 ident: B18 publication-title: Mol. Cell. Biol – volume: 25 start-page: 3831 year: 2005 ident: B86 publication-title: Mol. Cell. Biol doi: 10.1128/MCB.25.9.3831-3841.2005 – volume: 8 start-page: 355 year: 2005 ident: B62 publication-title: Cancer Cell doi: 10.1016/j.ccr.2005.10.015 – volume: 179 start-page: 1453 year: 2007 ident: B83 publication-title: J. Cell Biol doi: 10.1083/jcb.200707063 – volume: 411 start-page: 355 year: 2001 ident: B7 publication-title: Nature doi: 10.1038/35077225 – volume: 276 start-page: 42843 year: 2001 ident: B90 publication-title: J. Biol. Chem doi: 10.1074/jbc.M102116200 – volume: 24 start-page: 6432 year: 2005 ident: B3 publication-title: Oncogene doi: 10.1038/sj.onc.1208796 – volume: 309 start-page: 127 year: 2005 ident: B11 publication-title: Science doi: 10.1126/science.1110340 – volume: 20 start-page: 299 year: 2010 ident: B87 publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2010.01.009 – volume: 194 start-page: 275 year: 2001 ident: B21 publication-title: J. Exp. Med doi: 10.1084/jem.194.3.275 – volume: 200 start-page: 1681 year: 2004 ident: B95 publication-title: J. Exp. Med doi: 10.1084/jem.20041247 – volume: 315 start-page: 697 year: 2009 ident: B24 publication-title: Exp. Cell Res doi: 10.1016/j.yexcr.2008.07.022 – volume: 25 start-page: 402 year: 2001 ident: B50 publication-title: Methods doi: 10.1006/meth.2001.1262 – volume: 194 start-page: 265 year: 2001 ident: B99 publication-title: J. Exp. Med doi: 10.1084/jem.194.3.265 – volume: 4 start-page: e7728 year: 2009 ident: B19 publication-title: PLoS One doi: 10.1371/journal.pone.0007728 – volume: 9 start-page: 601 year: 2004 ident: B78 publication-title: Genes Cells doi: 10.1111/j.1356-9597.2004.00748.x – volume: 100 start-page: 617 year: 2008 ident: B79 publication-title: Biol. Cell doi: 10.1042/BC20080020 – volume: 21 start-page: 1717 year: 2009 ident: B55 publication-title: Cell. Signal doi: 10.1016/j.cellsig.2009.06.002 – volume: 41 start-page: 727 year: 1985 ident: B68 publication-title: Cell doi: 10.1016/S0092-8674(85)80053-2 – volume: 26 start-page: 2479 year: 2006 ident: B98 publication-title: Mol. Cell. Biol doi: 10.1128/MCB.26.7.2479-2489.2006 – volume: 14 start-page: 103 year: 2004 ident: B14 publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2004.01.004 – volume: 353 start-page: 172 year: 2005 ident: B46 publication-title: N. Engl. J. Med doi: 10.1056/NEJMra044389 – volume: 200 start-page: 1689 year: 2004 ident: B63 publication-title: J. Exp. Med doi: 10.1084/jem.20041306 – volume: 11 start-page: 143 year: 2006 ident: B33 publication-title: Genes Cells doi: 10.1111/j.1365-2443.2006.00926.x – volume: 90 start-page: 1357 year: 2010 ident: B54 publication-title: Invest – volume: 7 start-page: 441 year: 2007 ident: B57 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2147 – volume: 86 start-page: 2371 year: 1995 ident: B25 publication-title: Blood doi: 10.1182/blood.V86.6.2371.bloodjournal8662371 – volume: 18 start-page: 1748 year: 1999 ident: B64 publication-title: EMBO J doi: 10.1093/emboj/18.7.1748 – volume: 22 start-page: 3952 year: 2003 ident: B65 publication-title: Oncogene doi: 10.1038/sj.onc.1206620 – volume: 22 start-page: 159 year: 2006 ident: B41 publication-title: Annu. Rev. Cell Dev. Biol doi: 10.1146/annurev.cellbio.22.010605.093503 – volume: 91 start-page: 3927 year: 1998 ident: B43 publication-title: Blood doi: 10.1182/blood.V91.10.3927.3927_3927_3934 – volume: 19 start-page: 157 year: 2009 ident: B47 publication-title: Curr. Biol doi: 10.1016/j.cub.2008.12.007 – volume: 29 start-page: 263 year: 2010 ident: B96 publication-title: Oncogene doi: 10.1038/onc.2009.319 – volume: 298 start-page: 1912 year: 2002 ident: B52 publication-title: Science doi: 10.1126/science.1075762 – volume: 115 start-page: 626 year: 2010 ident: B69 publication-title: Blood doi: 10.1182/blood-2009-06-228130 – volume: 183 start-page: 4879 year: 2009 ident: B58 publication-title: J. Immunol doi: 10.4049/jimmunol.0901531 – volume: 19 start-page: 1219 year: 2008 ident: B27 publication-title: Ann. Oncol doi: 10.1093/annonc/mdn048 – volume: 8 start-page: 688 year: 1994 ident: B91 publication-title: Leukemia – volume: 182 start-page: 3974 year: 2009 ident: B31 publication-title: J. Immunol doi: 10.4049/jimmunol.0804172 – volume: 19 start-page: 1031 year: 1991 ident: B32 publication-title: Exp. Hematol – volume: 21 start-page: 3314 year: 2002 ident: B75 publication-title: Oncogene doi: 10.1038/sj.onc.1205317 – volume: 29 start-page: 5895 year: 2010 ident: B84 publication-title: Oncogene doi: 10.1038/onc.2010.331 – volume: 21 start-page: 140 year: 2009 ident: B36 publication-title: Curr. Opin. Cell Biol doi: 10.1016/j.ceb.2009.01.028 – volume: 281 start-page: 897 year: 2001 ident: B48 publication-title: Biochem. Biophys. Res. Commun doi: 10.1006/bbrc.2001.4430 – volume: 177 start-page: 613 year: 2007 ident: B88 publication-title: J. Cell Biol doi: 10.1083/jcb.200611063 – volume: 15 start-page: 4908 year: 1995 ident: B60 publication-title: Mol. Cell. Biol doi: 10.1128/MCB.15.9.4908 |
SSID | ssj0006903 |
Score | 2.1131024 |
Snippet | Article Usage Stats
Services
MCB
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley... Cellular transformation induced by oncogenic tyrosine kinases is a multistep process involving activation of growth-promoting signaling pathways and... |
SourceID | pubmedcentral proquest pubmed crossref informaworld highwire |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2552 |
SubjectTerms | Cell Line, Tumor Cell Transformation, Neoplastic - metabolism DNA-Binding Proteins - metabolism Down-Regulation Fusion Proteins, bcr-abl - metabolism Humans Lysine - metabolism Phosphoproteins - metabolism Proteasome Endopeptidase Complex - metabolism RNA-Binding Proteins - metabolism src-Family Kinases - metabolism Ubiquitin - metabolism Ubiquitination |
Title | Oncogenic Tyrosine Kinases Target Dok-1 for Ubiquitin-Mediated Proteasomal Degradation To Promote Cell Transformation |
URI | http://mcb.asm.org/content/31/13/2552.abstract https://www.tandfonline.com/doi/abs/10.1128/MCB.05045-11 https://www.ncbi.nlm.nih.gov/pubmed/21536658 https://www.proquest.com/docview/871387435 https://pubmed.ncbi.nlm.nih.gov/PMC3133381 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVFSB databaseName: Free Full-Text Journals in Chemistry customDbUrl: eissn: 1098-5549 dateEnd: 20250401 omitProxy: true ssIdentifier: ssj0006903 issn: 0270-7306 databaseCode: HH5 dateStart: 19810101 isFulltext: true titleUrlDefault: http://abc-chemistry.org/ providerName: ABC ChemistRy – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1098-5549 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0006903 issn: 0270-7306 databaseCode: KQ8 dateStart: 19890101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1098-5549 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0006903 issn: 0270-7306 databaseCode: KQ8 dateStart: 19810101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1098-5549 dateEnd: 20250401 omitProxy: true ssIdentifier: ssj0006903 issn: 0270-7306 databaseCode: DIK dateStart: 19810101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1098-5549 dateEnd: 20250401 omitProxy: true ssIdentifier: ssj0006903 issn: 0270-7306 databaseCode: GX1 dateStart: 19810101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1098-5549 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0006903 issn: 0270-7306 databaseCode: RPM dateStart: 19810101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXQEIKXCcZXGSA_wFOU4tj5fCwVaGIqCClDe7NiJxHRaApL8lB-PdcfSZOuSIyXKE2sKM05vj62fM9F6E1ZlgRokLu5n_iun0jiQgyEjpdFZSYKVhKispFXn8OzC__TZXC5226rs0taMZe_D-aV_A-qcA1wVVmyt0B2eChcgHPAF46AMBz_CeMvtdzAzUo66RZGOyUYz6saxqXGSfUOb9DHV66ntxJeiOpXV7VV7a50dY5CJwkAxM1mrUKfMo0w9ZWcVO3MULv0CmeplvbSkbi1KPY1oPriuiY9DhrrH9bZadidk9U2baxr2m2dOYt5f-sbhJcFDM976wP5bl01Gi9DpDcqgpgBxkRVZVoKuiUZh10b_C292DiIBsbU1g7IIMqCw8GeqgSG1fL9nASgTF0btaf22R4FgeYpl9u7NApDVeTi_OvOUD5MCOvzIWj8bvywqVLp3aP3LG0PTUz299eOBEv6EB3bmQZeGNo8QneK-gTdM7VHtyfo_rIv9fcYdQORcE8kbImEDZGwJhKGN8I3iYRHRMIjIuF0gy2RsCISnhLpCUo_fkiXZ66tx-FKn5IWBs4kI3AqYQ4hacCyUniUlERS5aopEpFLGgqlaT0aUhGCeBdEsCRIZBJJxp6io3pTF88RzpOcCulFoYyknxdBRgVIz6igcZFnMCGfIaf_9Fxar3pVMuUH13NWGnMAimug4OcMvR1a_zQeLX9pd9qjyLNmzddScOZxj3HFuBkiY2B5qxldGjJDu4MPxD34HBBTvSyri03X8DjyWAziPJihZ4YLw5vBH2UhfKMZiiYsGRoow_fpnbr6ro3fmccYKOwXt3_TU_Rg12lfoqP2uitegZpuxWvdH_4Afa7PIQ |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oncogenic+Tyrosine+Kinases+Target+Dok-1+for+Ubiquitin-Mediated+Proteasomal+Degradation+To+Promote+Cell+Transformation&rft.jtitle=Molecular+and+cellular+biology&rft.au=Janas%2C+Justyna+A.&rft.au=Van+Aelst%2C+Linda&rft.date=2011-07-01&rft.pub=Taylor+%26+Francis&rft.eissn=1098-5549&rft.volume=31&rft.issue=13&rft.spage=2552&rft.epage=2565&rft_id=info:doi/10.1128%2FMCB.05045-11&rft.externalDocID=12273105 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-7306&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-7306&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-7306&client=summon |